Lv41
720 积分 2023-09-08 加入
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
1个月前
已完结
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
1个月前
已完结
Top advances of the year: Small cell lung cancer
2个月前
已完结
Small Cell Lung Cancer
2个月前
已完结
Low-Grade Malignant Myofibroblastic Sarcoma of the Larynx: A Case Report and Literature Review
3个月前
已完结
Oral and Maxillofacial Low-Grade Myofibroblastic Sarcoma: A Systematic Review
3个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
11个月前
已完结
LEAP-002 - Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
2年前
已完结
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
2年前
已完结
皖公网安备34019202002308
